Skip to main content
OpenTrials

Clinical trial condition

Endocrine System Diseases

Explore clinical trials studying Endocrine System Diseases. Study availability and eligibility vary by location and protocol.

89 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Endocrine System Diseases trial results

Completed

A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes

NCT05691712

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Diabetes Type 2, +5 more
Locations
  • The Second People's Hospital of Hefei Hefei, Anhui, China
  • Beijing Hospital Beijing, Beijing Municipality, China
  • Beijing Pinggu District Hospital Beijing, Beijing Municipality, China
  • Chongqing General Hospital Chongqing, Chongqing Municipality, China
View all 25 locations
View Trial Details
Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03037385

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UC Irvine Medical Center Orange, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 71 locations
View Trial Details
Completed

A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes

NCT04809220

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +6 more
Locations
  • Nakayama Clinic Nagoya, Aichi-ken, Japan
  • Tosaki Clinic for Diabetes and Endocrinology Nagoya, Aichi-ken, Japan
  • Kashiwa City Hospital Kashiwa, Chiba, Japan
  • Kobari General Clinic Noda, Chiba, Japan
View all 44 locations
View Trial Details

Related conditions